The efficacy and safety of hydroxychloroquine versus leflunomide in patients with IgA nephropathy: a single-center experience
CONCLUSION: Both hydroxychloroquine combined with a renin-angiotensin system inhibitor and leflunomide combined with a renin-angiotensin system inhibitor were more effective than a renin-angiotensin system inhibitor alone in improving proteinuria in IgAN patients. Hydroxychloroquine was more effective in reducing proteinuria, and leflunomide showed superiority in reducing hematuria. Our results need to be verified in large-scale randomized controlled trials.PMID:38225440 | DOI:10.1007/s40620-023-01839-x
Source: Journal of Nephrology - Category: Urology & Nephrology Authors: Wei-Jie He Juan Wang Nan Liu Gu-Yue Li Xin-Wang Zhu Li Yao Lin-Lin Liu Source Type: research
More News: Databases & Libraries | Hydroxychloroquine | Proteinuria | Statistics | Urology & Nephrology